Ronald E Gangnon1,2,3, Natasha K Stout4, Oguzhan Alagoz2,3,5, John M Hampton2,3, Brian L Sprague6, Amy Trentham-Dietz2,3. 1. Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI, USA. 2. Department of Population Health Sciences, University of Wisconsin-Madison, Madison, WI, USA. 3. Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI. 4. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA. 5. Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA. 6. Department of Surgery and University of Vermont Cancer Center, Burlington, VT, USA.
Abstract
OBJECTIVE: Breast cancer simulation models must take changing mortality rates into account to evaluate the potential impact of cancer control interventions. We estimated mortality rates due to breast cancer and all other causes combined to determine their impact on overall mortality by year, age, and birth cohort. METHODS: Based on mortality rates from publicly available datasets, an age-period-cohort model was used to estimate the proportion of deaths due to breast cancer for US women aged 0 to 119 years, with birth years 1900 to 2000. Breast cancer mortality was calculated as all-cause mortality multiplied by the proportion of deaths due to breast cancer; other-cause mortality was the difference between all-cause and breast cancer mortality. RESULTS: Breast cancer and other-cause mortality rates were higher for older ages and birth cohorts. The percent of deaths due to breast cancer increased across birth cohorts from 1900 to 1940 then decreased. Among 50-year-old women, in the 1920 birth cohort, 52 (9.9%) of 100,000 deaths (95% CI, 9.8% to 10.1%) were attributed to breast cancer whereas 476 of 100,000 were due to other causes; in the 1960 birth cohort, 22 (8.5%) of 100,000 deaths (95% CI, 8.3% to 8.7%) were attributed to breast cancer with 242 of 100,000 deaths due to other causes. The percentage of all deaths due to breast cancer was highest (4.1% to 12.9%) for women in their 40s and 50s for all birth cohorts. CONCLUSIONS: This study offers evidence that advances in breast cancer screening and treatment have reduced breast cancer mortality for women across the age spectrum, and provides estimates of age-, year- and birth cohort-specific competing mortality rates for simulation models. Other-cause mortality estimates are important in these models because most women die from causes other than breast cancer.
OBJECTIVE:Breast cancer simulation models must take changing mortality rates into account to evaluate the potential impact of cancer control interventions. We estimated mortality rates due to breast cancer and all other causes combined to determine their impact on overall mortality by year, age, and birth cohort. METHODS: Based on mortality rates from publicly available datasets, an age-period-cohort model was used to estimate the proportion of deaths due to breast cancer for US women aged 0 to 119 years, with birth years 1900 to 2000. Breast cancer mortality was calculated as all-cause mortality multiplied by the proportion of deaths due to breast cancer; other-cause mortality was the difference between all-cause and breast cancer mortality. RESULTS:Breast cancer and other-cause mortality rates were higher for older ages and birth cohorts. The percent of deaths due to breast cancer increased across birth cohorts from 1900 to 1940 then decreased. Among 50-year-old women, in the 1920 birth cohort, 52 (9.9%) of 100,000 deaths (95% CI, 9.8% to 10.1%) were attributed to breast cancer whereas 476 of 100,000 were due to other causes; in the 1960 birth cohort, 22 (8.5%) of 100,000 deaths (95% CI, 8.3% to 8.7%) were attributed to breast cancer with 242 of 100,000 deaths due to other causes. The percentage of all deaths due to breast cancer was highest (4.1% to 12.9%) for women in their 40s and 50s for all birth cohorts. CONCLUSIONS: This study offers evidence that advances in breast cancer screening and treatment have reduced breast cancer mortality for women across the age spectrum, and provides estimates of age-, year- and birth cohort-specific competing mortality rates for simulation models. Other-cause mortality estimates are important in these models because most women die from causes other than breast cancer.
Entities:
Keywords:
age-period-cohort modeling; breast cancer; mortality; simulation modeling
Authors: Jeanne S Mandelblatt; Natasha K Stout; Clyde B Schechter; Jeroen J van den Broek; Diana L Miglioretti; Martin Krapcho; Amy Trentham-Dietz; Diego Munoz; Sandra J Lee; Donald A Berry; Nicolien T van Ravesteyn; Oguzhan Alagoz; Karla Kerlikowske; Anna N A Tosteson; Aimee M Near; Amanda Hoeffken; Yaojen Chang; Eveline A Heijnsdijk; Gary Chisholm; Xuelin Huang; Hui Huang; Mehmet Ali Ergun; Ronald Gangnon; Brian L Sprague; Sylvia Plevritis; Eric Feuer; Harry J de Koning; Kathleen A Cronin Journal: Ann Intern Med Date: 2016-01-12 Impact factor: 25.391
Authors: Carol E DeSantis; Stacey A Fedewa; Ann Goding Sauer; Joan L Kramer; Robert A Smith; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2015-10-29 Impact factor: 508.702
Authors: Tim Byers; Richard C Wender; Ahmedin Jemal; Arnold M Baskies; Elizabeth E Ward; Otis W Brawley Journal: CA Cancer J Clin Date: 2016-05-13 Impact factor: 508.702
Authors: Brian L Sprague; Natasha K Stout; Clyde Schechter; Nicolien T van Ravesteyn; Mucahit Cevik; Oguzhan Alagoz; Christoph I Lee; Jeroen J van den Broek; Diana L Miglioretti; Jeanne S Mandelblatt; Harry J de Koning; Karla Kerlikowske; Constance D Lehman; Anna N A Tosteson Journal: Ann Intern Med Date: 2015-02-03 Impact factor: 25.391
Authors: M Alan Brookhart; Amanda R Patrick; Colin Dormuth; Jerry Avorn; William Shrank; Suzanne M Cadarette; Daniel H Solomon Journal: Am J Epidemiol Date: 2007-05-15 Impact factor: 4.897
Authors: Y Claire Wang; Barry I Graubard; Marjorie A Rosenberg; Karen M Kuntz; Ann G Zauber; Lisa Kahle; Clyde B Schechter; Eric J Feuer Journal: Med Decis Making Date: 2012-11-06 Impact factor: 2.583
Authors: Sylvia K Plevritis; Diego Munoz; Allison W Kurian; Natasha K Stout; Oguzhan Alagoz; Aimee M Near; Sandra J Lee; Jeroen J van den Broek; Xuelin Huang; Clyde B Schechter; Brian L Sprague; Juhee Song; Harry J de Koning; Amy Trentham-Dietz; Nicolien T van Ravesteyn; Ronald Gangnon; Young Chandler; Yisheng Li; Cong Xu; Mehmet Ali Ergun; Hui Huang; Donald A Berry; Jeanne S Mandelblatt Journal: JAMA Date: 2018-01-09 Impact factor: 56.272
Authors: Amy Trentham-Dietz; Mehmet Ali Ergun; Oguzhan Alagoz; Natasha K Stout; Ronald E Gangnon; John M Hampton; Kim Dittus; Ted A James; Pamela M Vacek; Sally D Herschorn; Elizabeth S Burnside; Anna N A Tosteson; Donald L Weaver; Brian L Sprague Journal: Breast Cancer Res Treat Date: 2017-11-28 Impact factor: 4.872
Authors: Young Chandler; Clyde B Schechter; Jinani Jayasekera; Aimee Near; Suzanne C O'Neill; Claudine Isaacs; Charles E Phelps; G Thomas Ray; Tracy A Lieu; Scott Ramsey; Jeanne S Mandelblatt Journal: J Clin Oncol Date: 2018-01-08 Impact factor: 44.544
Authors: Jennifer M Yeh; Kathryn P Lowry; Clyde B Schechter; Lisa R Diller; Oguzhan Alagoz; Gregory T Armstrong; John M Hampton; Wendy Leisenring; Qi Liu; Jeanne S Mandelblatt; Diana L Miglioretti; Chaya S Moskowitz; Kevin C Oeffinger; Amy Trentham-Dietz; Natasha K Stout Journal: Ann Intern Med Date: 2020-07-07 Impact factor: 25.391
Authors: Kathryn P Lowry; H Amarens Geuzinge; Natasha K Stout; Oguzhan Alagoz; John Hampton; Karla Kerlikowske; Harry J de Koning; Diana L Miglioretti; Nicolien T van Ravesteyn; Clyde Schechter; Brian L Sprague; Anna N A Tosteson; Amy Trentham-Dietz; Donald Weaver; Martin J Yaffe; Jennifer M Yeh; Fergus J Couch; Chunling Hu; Peter Kraft; Eric C Polley; Jeanne S Mandelblatt; Allison W Kurian; Mark E Robson Journal: JAMA Oncol Date: 2022-04-01 Impact factor: 33.006
Authors: Marc D Ryser; Jane Lange; Lurdes Y T Inoue; Ellen S O'Meara; Charlotte Gard; Diana L Miglioretti; Jean-Luc Bulliard; Andrew F Brouwer; E Shelley Hwang; Ruth B Etzioni Journal: Ann Intern Med Date: 2022-03-01 Impact factor: 51.598
Authors: Oguzhan Alagoz; Donald A Berry; Harry J de Koning; Eric J Feuer; Sandra J Lee; Sylvia K Plevritis; Clyde B Schechter; Natasha K Stout; Amy Trentham-Dietz; Jeanne S Mandelblatt Journal: Med Decis Making Date: 2018-04 Impact factor: 2.583
Authors: Kathryn P Lowry; Amy Trentham-Dietz; Clyde B Schechter; Oguzhan Alagoz; William E Barlow; Elizabeth S Burnside; Emily F Conant; John M Hampton; Hui Huang; Karla Kerlikowske; Sandra J Lee; Diana L Miglioretti; Brian L Sprague; Anna N A Tosteson; Martin J Yaffe; Natasha K Stout Journal: J Natl Cancer Inst Date: 2020-06-01 Impact factor: 13.506
Authors: Amy Trentham-Dietz; Oguzhan Alagoz; Christina Chapman; Xuelin Huang; Jinani Jayasekera; Nicolien T van Ravesteyn; Sandra J Lee; Clyde B Schechter; Jennifer M Yeh; Sylvia K Plevritis; Jeanne S Mandelblatt Journal: PLoS Comput Biol Date: 2021-06-17 Impact factor: 4.475
Authors: Jennifer M Yeh; Kathryn P Lowry; Clyde B Schechter; Lisa R Diller; Grace O'Brien; Oguzhan Alagoz; Gregory T Armstrong; John M Hampton; Melissa M Hudson; Wendy Leisenring; Qi Liu; Jeanne S Mandelblatt; Diana L Miglioretti; Chaya S Moskowitz; Paul C Nathan; Joseph P Neglia; Kevin C Oeffinger; Amy Trentham-Dietz; Natasha K Stout Journal: J Natl Cancer Inst Date: 2022-02-07 Impact factor: 11.816